Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors

(NASDAQ:PRLD),(NASDAQ:INCY), Incyte secures an exclusive option to acquire Prelude's mutant selective JAK2V617F JH2 inhibitor program Mutant selective JAK2V617F JH2 inhibitors have disease-modifying potential in treating patients living with myeloproliferative neoplasms (MPNs) Prelude to receive a $35 million upfront payment and $25 million strategic equity investment, $100 million if Incyte were to exercise the option to […]

Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer

(NASDAQ:RLMD), Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized controlled trial in intermediate-risk NMIBC. FDA Feedback also confirms no additional non-clinical studies are required. 9-month follow-up for NDV-01 showed a 92%

Geography Shouldn’t Determine Access to Justice: New Report Reveals Deep Inequities in Forensic Evidence Collection for Sexual Assault Survivors in Canada’s Remote and Indigenous Communities

TORONTO, Nov. 04, 2025 (GLOBE NEWSWIRE) — A groundbreaking new report from She Matters, funded by the Ministry of Women and Gender Equality Canada (WAGE), reveals that a survivor's location in Canada can dramatically affect their chances of receiving justice after sexual assault. The study, Does Geography Impact Access to Justice? Access to Evidence Collection

CYTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cytokinetics, Incorporated Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ:CYTK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Long Home Launches “Project Rebuild” to Support Homeowners Impacted by NEWPRO Closure

Company steps in to help homeowners complete unfinished projects and rebuild trust across New England Following the sudden closure of NEWPRO Home Solutions on Tuesday, October 28, hundreds of homeowners across New England have been left with unfinished bathroom remodels, roof replacements, and other home improvement projects. https://mma.prnewswire.com/media/2812488/LONG_HOME_Long_Home_Launches__Project_Rebuild__to_Support_Homeow.jpg In response, Long Home, a trusted family-owned

BOARDWALKTECH RENEWS AND EXPANDS BUSINESS WITH KEY GLOBAL CUSTOMERS

Global Social Media Leader Renews and Expands Major Outsourcing Services Firm Expands Usage Global Chemical Company Scales Unity Central Deployment (TSXV: BWLK) (OTCQB: BWLKF) – Boardwalktech Software Corp. (“Boardwalktech” or the “Company”), a leading digital ledger platform and AI enterprise software solutions company, announces several contract renewals and expansions increasing recurring revenue across multiple major

Heartland Forward Launches Center to Fuel Investment Across America’s Heartland

'Center for Investment Readiness' to Support 30 Heartland Communities by 2030 Today, Heartland Forward announced the launch of the Center for Investment Readiness (CIR), a dedicated hub for research and strategic program development to enhance investor confidence and support new and thriving businesses in the heartland. CIR's cornerstone initiative, 30 by 2030 will create a

HAMILTON LANE INCORPORATED REPORTS SECOND QUARTER FISCAL 2026 RESULTS

Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the second fiscal quarter ended September 30, 2025. The Company issued a full detailed presentation of its second quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. DividendHamilton Lane has declared a quarterly

URBAN ONE, INC. REPORTS THIRD QUARTER 2025 RESULTS

Urban One, Inc. (NASDAQ: UONEK and UONE) today reported its results for the three months ended September30, 2025. For the three months ended September30, 2025, net revenue was approximately $92.7million, a decrease of 16.0% from the same period in 2024. The Company reported operating income of approximately $2.5million for the three months ended September30, 2025,

NewcelX CEO Issues Letter to Shareholders

NewcelX Ltd. (Nasdaq: NCEL), a Swiss clinical-stage biopharmaceutical company developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, integrating regenerative medicine and neuroscience expertise within a unified platform, today issued a letter to its shareholders. https://mma.prnewswire.com/media/2809532/NewCelX_Logo.jpg Dear Shareholders, The future of NewcelX Ltd. (Nasdaq: NCEL) (“NewcelX” or the “Company”) begins now. Our Company stands

Scroll to Top